Markku Vähätalo

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

H Yki-Järvinen, Mirja Tiikkainen, Markku Vähätalo et al. · Diabetologia · 2006 · 435 citations · Full text

Metabolic Syndrome, Diabetes Management, Insulin Glargine +10

Initiate Insulin by Aggressive Titration and Education (INITIATE)

Hannele Yki‐Järvinen, Leena Juurinen, Michael Alvarsson et al. · Diabetes Care · 2007 · 137 citations · Full text

A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial

Eero Mattila, Veli-Jukka Anttila, Markku Broas et al. · Scandinavian Journal of Infectious Diseases · 2008 · 77 citations

Veterinary Vaccine, Dysbiosis, Preliminary Study Cdiw +19

Dupuytren's disease in type 1 diabetic patients: a five-year prospective study.

Perttu Arkkila, Ilkka Kantola, Jorma Viikari et al. · PubMed · 1996 · 66 citations

Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients

Risto Huupponen, Aapo Lehtonen, Markku Vähätalo · European Journal of Clinical Pharmacology · 1992 · 48 citations

Metabolic Syndrome, Hypertension, Insulin Sensitivity +8